• Bottaro, D.P., Pubin, J.S., Faletto, D.L., Chan, A.M.L., Kmiecik, T.E., Van de Woude, G.F. & Aaronson, S.A. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science, 251, 802804.
  • Di Renzo, M.F., Olivero, M., Serini, G., Orlandi, F., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., Angeli, A., Pierotti, M.A. & Comoglio, P.M. (1995) Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. Journal of Endocrinological Investigation, 18, 134139.
  • Hsiao, L.T., Lin, J.T., Yu, I.T., Chiou, T.J., Liu, J.H., Yen, C.C., Wang, W.S. & Chen, P.M. (2003) High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma. European Journal of Haematology, 70, 282289.
  • Humphrey, P.A., Zhu, X., Zarnegar, R., Swanson, P.E., Ratliff, T.L., Vollmer, R.T. & Day, M.L. (1995) Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. American Journal of Pathology, 147, 386396.
  • Kimiecik, T.E., Keller, J.R., Rosen, E. & Vande Woude, G.F. (1992) Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood, 180, 24542457.
  • Matsumoto, K. & Nakamura, T. (1996) Emerging multipoint aspects of hepatocyte growth factor. Journal of Biochemistry, 119, 591600.
  • Ohshima, K., Kawasaki, C., Muta, H., Muta, K., Deyev, V., Haraoka, S., Suzumiya, J., Podack, E.R. & Kikuchi, M. (2001) CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology, 39, 156162
  • Shipp, M.A., Harrington, D.P., Anderson, J.R., Armitage, J.O., Bonadonna, G., Brittinger, G., Cabanillas, F., Canellos, G.P., Coiffier, B., Connors, J.M., Cowan, R.A., Crowther, D., Dahlberg, S., Engelhard, M., Fisher, R.I., Gisselbrecht, C., Horning, S.J., Lepage, E., Lister, T.A., Meerwaldt, J.H., Montserrat, E., Nissen, N.I., Oken, M.M., Peterson, B.A., Tondini, C., Velasquez, W.A. & Yeap, B.Y. (1993) The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987994.
  • Umeki, K., Shiota, G. & Kawasaki, H. (1999) Clinical significance of c-met oncogene alterations in human colorectal cancer. Oncology, 56, 314321.
  • Weimar, I.S., de Jong, D., Muller, E.J., Nakamura, T., van Gorp, J.M.H.H., de Gast, G.C. & Gerritsen, W.R. (1997) Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via α4β1 and α5β1 integrins. Blood, 89, 9901000.
  • Weimar, I.S., Weijer, K., van den Berk, P.C.M., Muller, E.J., Miranda, N., Bakker, A.Q., Heemskerk, M.H.M., Hekman, A., de Gast, G.C. & Gerritsen, W.R. (1999) HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice. British Journal of Cancer, 81, 4353.
  • Yonemura, Y., Kaji, M., Hirono, Y., Fushida, S., Tsugawa, K., Fujimura, T., Miyazaki, I., Harada, S. & Yamamoto, H. (1996) Correlation between overexpression of c-met gene and the progression of gastric cancer. International Journal of Oncology, 8, 555560.